Product Program year 2020 Source: CMS Open Payments

ADVIA Immunoassay Reagents/Test Kit/Clinical Utilization

Device DX - Diagnostics incl. all products and services

Open in the dashboard

General payments

$100,466

69 payments

Research payments

$7,730,498

442 payments

Through program year 2020, $100,466 in general payments and $7,730,498 in research payments were reported against ADVIA Immunoassay Reagents/Test Kit/Clinical Utilization (DX - Diagnostics incl. all products and services).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $50,691 21
2020 Research $4,133,135 257
2019 General $49,775 48
2019 Research $3,597,363 185

Breakdown

Who paid General payments · program years 2019–2020
  1. Siemens Medical Solutions USA, Inc. $100,466 69 payments
Top recipients General payments · program year 2020
  1. Allan Jaffe Cardiovascular Disease · Rochester, MN $16,604 33% · 4 payments
  2. James Januzzi Cardiovascular Disease · Boston, MA $15,000 30% · 5 payments
  3. Mazen Noureddin Gastroenterology · Houston, TX $6,900 14% · 1 payment
  4. Mary Rinella Gastroenterology · Chicago, IL $5,000 10% · 1 payment
  5. Zobair Younossi Surgery · Falls Church, VA $3,750 7% · 1 payment

The top 5 of 13 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Cardiovascular Disease Internal Medicine $31,604 62% · 2 practitioners
  2. Gastroenterology Internal Medicine $13,438 27% · 3 practitioners
  3. Surgery $3,750 7% · 1 practitioner
  4. Endocrinology, Diabetes & Metabolism Internal Medicine $1,800 4% · 1 practitioner
  5. Anatomic Pathology & Clinical Pathology Pathology $99 <1% · 6 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Minnesota $16,604 33% · 1 recipient
  2. Massachusetts $15,000 30% · 1 recipient
  3. Virginia $7,088 14% · 3 recipients
  4. California $6,900 14% · 1 recipient
  5. Illinois $5,000 10% · 1 recipient

The top 5 of 8 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

69 general · 442 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record